Li Ping

Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial

G. Qin, Zi-lin Sun, Liujun Fu, 2021, Diabetes, obesity & metabolism.